DFTX R&D Expenses
Definium Therapeutics Inc · R&D Expenses
DFTX R&D Expenses
Latest reported$154.65Mperiod ending
DFTX TTM R&D Expenses ($0.00 → $154.65M)
TTM R&D Expenses
High-resolution chart · PNG
DFTX r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 154,648,000 | |
| 135,792,000 | |
| 117,665,000 | |
| 105,903,000 | |
| 92,113,000 | |
| 76,949,000 | |
| 64,770,000 | |
| 54,557,000 | |
| 50,572,000 | |
| 50,704,000 | |
| 52,125,000 | |
| 49,409,000 | |
| 43,978,000 | |
| 38,527,000 | |
| 36,169,000 | |
| 38,222,000 | |
| 39,469,000 | |
| 38,217,000 | |
| 34,789,000 | |
| 32,063,000 | |
| 28,386,000 | |
| 23,012,000 | |
| 18,002,000 | |
| 10,270,185 | |
| 4,928,185 | |
| 2,228,185 | |
| 425,185 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |